Search for: "AstraZeneca Inc."
Results 241 - 260
of 340
Sorted by Relevance
|
Sort by Date
8 Jun 2015, 4:20 am
******************PREVIOUSLY, ON NEVER TOO LATE Never too late 48 [week ending on Sunday 31 May] - The meaning of EPO appeal system | 3D Printing and the law | Epo and external investigation firms | Umbrella designs | US Supreme Court in Commil USA, LLC v Cisco Systems | European Inventor Award | FIFA and brand integrity | Warner-Lambert v Actavis | Wine in Black GmbH v OHIM | IP and busking | Swiss-style claims.Never too late… [read post]
17 Jan 2008, 10:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at [feeds.feedburner.com]Highlights this week included:The European antitrust raids on Pfizer, AstraZeneca, Glaxo, Sanofi-Aventis: (IP Law360), (Wall Street Journal Health Blog), (IAM), (IPEG), (SmartBrief), (In the pipeline),Hasbro and Mattel alleged trade mark infringement and demand shut down of Scrabulous, a free online gaming site allowing users to play a version of… [read post]
24 Feb 2011, 1:49 pm
Astrazeneca Pharmaceuticals, 832 A.2d 1241, 1243 (Conn. [read post]
19 Sep 2013, 9:53 am
Pfizer, Inc., 712 F.3d 21 (1st Cir. 2013), Aetna, Inc. v. [read post]
13 May 2010, 12:27 pm
Astrazeneca Pharmaceuticals LP, 2009 WL 2231686 (M.D. [read post]
24 Dec 2009, 11:32 am
AstraZeneca LP v. [read post]
27 Oct 2010, 8:57 am
Trailing just behind was AstraZeneca, which paid $520 million over allegations it inappropriately marketed its psychiatric drug Seroquel. [read post]
15 Feb 2011, 5:26 pm
(FDA Law Blog) Diovan (Vasartan) – France: Novartis v Actavis – preliminary injunction for Valsartan confirmed (The SPC Blog) Diovan HTC (Valsartan) – Belgium: Antwerp Court of Appeal stops infringement of Valsartan/HCTZ SPC based on patent claiming Valsartan alone: Novartis v Teva (The SPC Blog) Lescol (Fluvastatin) – US: Novartis files patent infringement complaint against Mylan following Para IV challenge (Patent Docs) (GenericsWeb) Mucinex (Guaifenesin) – US: Watson… [read post]
13 Jan 2010, 3:00 am
Cobrek Pharmaceuticals, Inc (Patent Docs) Nexium (Esomeprazole) – US: Teva drops patent challenge following settlement agreement with AstraZeneca over Nexium (IP Factor) (GenericsWeb) Nuvigil (Armodafinil) - US: Mylan confirms first-to-file patent challenge relating to sleep-disorder drug (SmartBrief) Nuvigil (Armodafinil) - US: Cephalon sues Watson for patent infringement following Para IV challenge (Patent Docs) (GenericsWeb) (Patentcircle) Tasigna (Nilotinib) - India:… [read post]
20 Jul 2010, 6:00 am
Holdings, Inc. [read post]
10 Aug 2010, 6:10 am
Astrazeneca Pharmaceuticals LP, 585 F. [read post]
12 Aug 2013, 10:02 pm
Atkins Foundation, the Ann Arbor Area Community Foundation, the Allen Foundation, AstraZeneca, HealthCare Foundation, Borders Inc, and the Robert Beard Foundation. [read post]
3 Oct 2015, 4:13 pm
AstraZeneca Pharm., L.P., 958 So. 2d 1054, 1056 (Fla. 3d DCA 2007). [read post]
16 Aug 2016, 1:38 pm
She was a financial accountant for IPR Pharmaceuticals, Inc. at Astrazeneca P.L.C. where she was in charge of the preparation and filing of corporate tax forms, analysis of monthly income tax computation, set up pricing commerce reports, preparation of account’s reconciliations, journal cash postings and accounts receivable statements. [read post]
28 Nov 2011, 5:00 am
Abbott Laboratories, Inc., 716 F.Supp.2d 740 (N.D. [read post]
16 Jul 2010, 12:10 pm
., Inc. v. [read post]
27 Oct 2010, 8:57 am
Trailing just behind was AstraZeneca, which paid $520 million over allegations it inappropriately marketed its psychiatric drug Seroquel. [read post]
27 Apr 2010, 10:58 pm
(Patent Docs) Prilosec (Omeprazole) – US: Dr Reddy’s wins attorney’s fees from AstraZeneca in Prilosec OTC case (Orange Book Blog) Protonix (Pantoprazole) – US: Jury finds Protonix patent infringed by Teva (The IP Factor) Restasis (Ciclosporin) – Restasis royalty dispute finally settles (IP finance) Tarceva (Erlotinib) – India: Roche and Tarceva in Delhi HC again, this time vs Natco (Spicy IP) (Generic Pharmaceuticals and IP) Viagra (Sildenafil) –… [read post]
9 Mar 2011, 3:00 am
Allergan, Inc (Chicago IP Litigation Blog) Synagis (Palivizumab) – US: PDL BioPharma settles Medimmune Synagis litigation for $93M (Patent Docs) TriCor (Fenofibrate) – US: Abbott and Elan end TriCor suit with Ranbaxy (Patent Docs) Valsartan – Norway: Oslo District Court holds Actavis’ Valsartan/HCTZ product infringes Novartis’ patent covering synthesis route for Valsartan; deals inter alia with scope of Valsartan SPC (The SPC Blog) [read post]
12 Jan 2010, 7:26 am
"); AstraZeneca LP v. [read post]
